Cognitive Behavior Therapy for Health Anxiety: A Comparison of Three Forms of Self-help

Sponsor
Karolinska Institutet (Other)
Overall Status
Completed
CT.gov ID
NCT01966705
Collaborator
(none)
132
1
4
25
5.3

Study Details

Study Description

Brief Summary

Background

Severe health anxiety, Somatic symptom disorder or Illness anxiety disorder according to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5), is associated with considerable personal distress, functional disability and societal costs. Several studies have demonstrated the efficacy of Cognitive Behavior Therapy (CBT) for severe health anxiety, both on anxiety itself and on secondary symptom measures (for example of depression). One published randomized controlled trial (RCT) has examined the feasibility of delivering CBT for severe health anxiety via the Internet as a form of guided self help. Participants had contact with a therapist via an e-mail-like system throughout the treatment. This approach yielded results superior to a waiting-list condition, thus potentially greatly increasing the availability of psychological treatment. However, more studies on the effects of Internet-delivered CBT are warranted (NCT01673035 being one). Additionally, little is known about the active ingredients and mechanisms of change involved in Internet-delivered CBT. For example, the significance of therapist support in relation to treatment outcomes remains to be determined. CBT-based self-help literature, so called bibliotherapy, has shown great promise in the treatment of several anxiety disorders, including panic disorder and social anxiety disorder. Two small pilot studies have indicated that bibliotherapy with no or minimal therapist contact could be suitable for treating health anxiety.

Aim of the study

The aim of the present RCT is to compare therapist-guided Internet-delivered CBT (n=33), Internet-delivered CBT without therapist guidance (n=33), CBT-based bibliotherapy without therapist guidance (n=33) and a waiting-list control condition (n=33) for adult participants with severe health anxiety.

Participants in all treatment programs are expected to be significantly improved on measures of health anxiety, compared to participants allocated to the waiting-list condition.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behavior Therapy, exposure and response prevention (Internet, guided)
  • Behavioral: Cognitive Behavior Therapy, exposure and response prevention (Internet, unguided)
  • Behavioral: Cognitive Behavior Therapy, exposure and response prevention (Book, unguided)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
132 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Self-help Based Cognitive Behavior Therapy for Health Anxiety Delivered Via the Internet or in Book Form - the Effect of Administration Strategy and Therapist Contact: a Randomized Controlled Trial
Study Start Date :
Oct 1, 2013
Actual Primary Completion Date :
Nov 1, 2015
Actual Study Completion Date :
Nov 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Therapist-guided Internet-based Cognitive Behavior Therapy

Cognitive Behavior Therapy delivered via the Internet: 12 weeks, supported self-help

Behavioral: Cognitive Behavior Therapy, exposure and response prevention (Internet, guided)
This intervention entails different exercises aimed at exposure to health anxiety stimuli. Participants are guided by a therapist. Treatment is delivered via the Internet.

Experimental: Unguided Internet-based Cognitive Behavior Therapy

Cognitive Behavior Therapy delivered via the Internet: 12 weeks, self-help only

Behavioral: Cognitive Behavior Therapy, exposure and response prevention (Internet, unguided)
This intervention entails different exercises aimed at exposure to health anxiety stimuli. Participants are not guided by a therapist. Treatment is delivered via the Internet.

Experimental: Cognitive Behavior Therapy-based bibliotherapy

Cognitive Behavior Therapy delivered in book form: 12 weeks, self-help only

Behavioral: Cognitive Behavior Therapy, exposure and response prevention (Book, unguided)
This intervention entails different exercises aimed at exposure to health anxiety stimuli. Participants are not guided by a therapist. Treatment is delivered in book form.

No Intervention: Waiting-list condition

No intervention: 12 weeks

Outcome Measures

Primary Outcome Measures

  1. Health Anxiety Inventory (HAI) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in HAI at post-treatment and follow-ups compared to baseline

Secondary Outcome Measures

  1. Illness Attitude Scale (IAS) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in IAS at post-treatment and follow-ups compared to baseline

  2. Whiteley Index (WI) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in WI at post-treatment and follow-ups compared to baseline

  3. Montgomery-Åsberg Depression Rating Scale - Self report (MADRS-S) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in MADRS-S at post-treatment and follow-ups compared to baseline

  4. Beck Anxiety Inventory (BAI) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in BAI at post-treatment and follow-ups compared to baseline

  5. Anxiety Sensitivity Index (ASI) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in ASI at post-treatment and follow-ups compared to baseline

  6. Sheehan Disability Scale (SDS) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in SDS at post-treatment and follow-ups compared to baseline

  7. Trimbos and institute of medical technology assessment cost questionnaire (TIC-P) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in TIC-P at post-treatment and follow-ups compared to baseline

  8. Euroqol-5D (EQ-5D) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in EQ-5D at post-treatment and follow-ups compared to baseline

  9. Obsessive Compulsive Inventory Revised (OCI-R) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Only for assessing the sample on this symptom domain

  10. Yale-Brown Obsessive Compulsive Scale (Y-BOCS) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Only for assessing the sample on this symptom domain

  11. Alcohol Use Disorders Identification Test (AUDIT) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in AUDIT at post-treatment and follow-ups compared to baseline

  12. Insomnia Severity Index (ISI) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in ISI at post-treatment and follow-ups compared to baseline

  13. Self-rated health 5 (SRH-5) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in SRH-5 at post-treatment and follow-ups compared to baseline

  14. The Swedish Scales of Personalities [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in The Swedish Scales of Personalities at post-treatment and follow-ups compared to baseline

  15. Quality of Life Inventory (QOLI) [baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up]

    Change in QOLI at post-treatment and follow-ups compared to baseline

Other Outcome Measures

  1. Psychological mediators [week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12]

    Assessment of whether these mediators will precede change in outcome during the treatment. Mediators will be assessed using sub scales of the Health Anxiety Inventory, and the Insomnia Severity Index, Perceived Competence Scale, Working Alliance Inventory, Five Facet Mindfulness Questionnaire, Acceptance and Flexibility, and Somatosensory Amplification Scale

  2. The treatment credibility scale [Weeks 2 and 8]

    For assessing treatment credibility and expectancy of improvement

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • A primary diagnosis of severe health anxiety (somatic symptom disorder or illness anxiety disorder) according to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5)

  • At least 18 years old

  • Able to read and write in Swedish

Exclusion Criteria:
  • Other primary axis-I disorder

  • Ongoing substance abuse or addiction

  • Current or previous episode of psychosis or bipolar disorder

  • Severe major depressive disorder

  • Higher than 5 on the suicidality scale of the Mini International diagnostic Interview

  • Non-stable antidepressant medication (changed during the last 2 months) or not agreeing to keep dosage constant throughout the study

  • Ongoing concurrent psychological treatment for severe health anxiety

  • Having received previous high quality Cognitive Therapy or Cognitive Behavior Therapy during the recent year

  • Ongoing serious somatic disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Karolinska Institutet Stockholm Sweden 17177

Sponsors and Collaborators

  • Karolinska Institutet

Investigators

  • Principal Investigator: Erik Hedman, phd, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Erik Hedman, phd, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT01966705
Other Study ID Numbers:
  • InterBib
First Posted:
Oct 22, 2013
Last Update Posted:
Nov 5, 2015
Last Verified:
Nov 1, 2015

Study Results

No Results Posted as of Nov 5, 2015